{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T11:23:39Z","timestamp":1795087419902,"version":"4.10.2"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Microvascular inflammation (MVI), donor-specific antibodies (DSAs)-negative and C4d-negative, was recently defined as a distinct phenotype by Banff 2022 and has been associated with adverse clinical outcomes. We have developed a model for rejection-related molecular classification of renal allograft biopsies using gene expression profiling of formalin-fixed paraffin-embedded renal biopsy tissue and evaluated its performance in patients with MVI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>Using this updated gene expression profiling-based multiclass model, we evaluated 138 biopsy specimens obtained from a large US transplant center, which included 42 biopsies diagnosed as MVI, DSA-negative, and C4d-negative. Clinical outcomes of patients in this MVI biopsy group were analyzed in relation to their molecular classifications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>The molecular rejection classifications exhibited robust concordance with histology diagnoses of no rejection, antibody-mediated rejection, and T-cell\u2013mediated rejection in this independent cohort, with concordance rates varying in each group from 85% to 93%. The molecular classification also showed a significant association with differential renal function and graft survival in the MVI, DSA-negative, and C4d-negative group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Our model demonstrates significant molecular differentiation among antibody-mediated rejection, T-cell\u2013mediated rejection, and no rejection. In addition, our model classified MVI, DSA-negative, and C4d-negative samples into molecular subgroups associated with divergent clinical outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005822","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:00:39Z","timestamp":1784826039000},"page":"e2498-e2507","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Molecular Classification Predicts Clinical Outcomes of Kidney Transplant Recipients With Microvascular Inflammation, Donor-specific Antibodies-negative and C4d-negative"],"prefix":"10.1097","volume":"110","author":[{"given":"Fahad","family":"Aziz","sequence":"first","affiliation":[{"name":"Department of Medicine, School of Medicine and Public Health, University of Wisconsin\u2014Madison, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6129-0342","authenticated-orcid":false,"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[{"name":"CareDx, Inc., Brisbane, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peale","family":"Chuang","sequence":"additional","affiliation":[{"name":"CareDx, Inc., Brisbane, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlan","family":"Tian","sequence":"additional","affiliation":[{"name":"CareDx, Inc., Brisbane, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jijiao","family":"Zeng","sequence":"additional","affiliation":[{"name":"CareDx, Inc., Brisbane, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3057-6193","authenticated-orcid":false,"given":"James","family":"Lu","sequence":"additional","affiliation":[{"name":"CareDx, Inc., Brisbane, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Shen","sequence":"additional","affiliation":[{"name":"CareDx, Inc., Brisbane, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6966-4991","authenticated-orcid":false,"given":"Natali","family":"Gulbahce","sequence":"additional","affiliation":[{"name":"CareDx, Inc., Brisbane, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0929-8965","authenticated-orcid":false,"given":"Jana","family":"Kobrle","sequence":"additional","affiliation":[{"name":"CareDx, Inc., Brisbane, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Tobin","sequence":"additional","affiliation":[{"name":"CareDx, Inc., Brisbane, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7514-498X","authenticated-orcid":false,"given":"Robert","family":"Woodward","sequence":"additional","affiliation":[{"name":"CareDx, Inc., Brisbane, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2152-5469","authenticated-orcid":false,"given":"Shana","family":"Coley","sequence":"additional","affiliation":[{"name":"Clinical Biomarkers Center, Arkana Laboratories, Little Rock, AR."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8345-8292","authenticated-orcid":false,"given":"Johnathan","family":"Napier","sequence":"additional","affiliation":[{"name":"Clinical Biomarkers Center, Arkana Laboratories, Little Rock, AR."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7675-6128","authenticated-orcid":false,"given":"Arjang","family":"Djamali","sequence":"additional","affiliation":[{"name":"Department of Medicine, Maine Medical Center, Portland, ME."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7001-2168","authenticated-orcid":false,"given":"Neetika","family":"Garg","sequence":"additional","affiliation":[{"name":"Department of Medicine, School of Medicine and Public Health, University of Wisconsin\u2014Madison, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"R1-20261119","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1111\/ajt.12946","article-title":"Molecular landscape of T cell-mediated rejection in human kidney transplants: prominence of CTLA4 and PD ligands.","volume":"14","author":"Venner","year":"2014","journal-title":"Am J Transplant"},{"key":"R2-20261119","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/ajt.13115","article-title":"The molecular landscape of antibody-mediated kidney transplant rejection: evidence for NK involvement through CD16a Fc receptors.","volume":"15","author":"Venner","year":"2015","journal-title":"Am J Transplant"},{"key":"R3-20261119","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1097\/TP.0000000000000621","article-title":"Use of quantitative real time polymerase chain reaction to assess gene transcripts associated with antibody-mediated rejection of kidney transplants.","volume":"99","author":"Dominy","year":"2015","journal-title":"Transplantation"},{"key":"R4-20261119","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/ctr.12689","article-title":"Multiplexed color-coded probe-based gene expression assessment for clinical molecular diagnostics in formalin-fixed paraffin-embedded human renal allograft tissue.","volume":"30","author":"Adam","year":"2016","journal-title":"Clin Transplant"},{"key":"R5-20261119","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(16)30826-1","article-title":"Biopsy transcriptome expression profiling to identify kidney transplants at risk of chronic injury: a multicentre, prospective study.","volume":"388","author":"O\u2019Connell","year":"2016","journal-title":"Lancet"},{"key":"R6-20261119","doi-asserted-by":"crossref","first-page":"e94197","DOI":"10.1172\/jci.insight.94197","article-title":"Assessing rejection-related disease in kidney transplant biopsies based on archetypal analysis of molecular phenotypes.","volume":"2","author":"Reeve","year":"2017","journal-title":"JCI Insight"},{"key":"R7-20261119","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ekir.2018.09.005","article-title":"Molecular assessment of C4d-positive renal transplant biopsies without evidence of rejection.","volume":"4","author":"Dominy","year":"2019","journal-title":"Kidney Int Rep"},{"key":"R8-20261119","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1111\/ajt.15372","article-title":"WNT pathway signaling is associated with microvascular injury and predicts kidney transplant failure.","volume":"19","author":"Seifert","year":"2019","journal-title":"Am J Transplant"},{"key":"R9-20261119","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2215\/CJN.0000000000000100","article-title":"A simple molecular tool for the assessment of kidney transplant biopsies.","volume":"18","author":"de Nattes","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"R10-20261119","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/MNH.0000000000000974","article-title":"Biopsy-based transcriptomics in the diagnosis of kidney transplant rejection.","volume":"33","author":"de Nattes","year":"2024","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R11-20261119","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.kint.2023.11.012","article-title":"Transcriptomic signatures of chronic active antibody-mediated rejection deciphered by RNA sequencing of human kidney allografts.","volume":"105","author":"Shah","year":"2024","journal-title":"Kidney Int"},{"key":"R12-20261119","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/TP.0000000000004624","article-title":"The molecular phenotype of kidney transplants: insights from the MMDx project.","volume":"108","author":"Halloran","year":"2024","journal-title":"Transplantation"},{"key":"R13-20261119","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions.","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"R14-20261119","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/ajt.14107","article-title":"The Banff 2015 kidney meeting report: current challenges in rejection classification and prospects for adopting molecular pathology.","volume":"17","author":"Loupy","year":"2017","journal-title":"Am J Transplant"},{"key":"R15-20261119","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/ajt.14625","article-title":"The Banff 2017 kidney meeting report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.","volume":"18","author":"Haas","year":"2018","journal-title":"Am J Transplant"},{"key":"R16-20261119","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1111\/ajt.16059","article-title":"Banff 2019 meeting report: molecular diagnostics in solid organ transplantation-consensus for the Banff Human Organ Transplant (B-HOT) gene panel and open source multicenter validation.","volume":"20","author":"Mengel","year":"2020","journal-title":"Am J Transplant"},{"key":"R17-20261119","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajt.2023.10.016","article-title":"The Banff 2022 kidney meeting report: reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics.","volume":"24","author":"Naesens","year":"2024","journal-title":"Am J Transplant"},{"key":"R18-20261119","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.ajt.2026.01.018","article-title":"The Banff 2024 kidney meeting report: rejection as a spectrum of phenotypes and focus on differential diagnostic reasoning.","volume":"26","author":"Naesens","year":"2026","journal-title":"Am J Transplant"},{"key":"R19-20261119","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1111\/ajt.17087","article-title":"Evolving the surveillance and workup of heart transplant rejection: a real-world analysis of the molecular microscope diagnostic system.","volume":"22","author":"Alam","year":"2022","journal-title":"Am J Transplant"},{"key":"R20-20261119","doi-asserted-by":"crossref","first-page":"13817","DOI":"10.3390\/ijms241813817","article-title":"Discrepancy analysis between histology and molecular diagnoses in kidney allograft biopsies: a single-center experience.","volume":"24","author":"Suo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R21-20261119","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa2400763","article-title":"A randomized phase 2 trial of felzartamab in antibody-mediated rejection.","volume":"391","author":"Mayer","year":"2024","journal-title":"N Engl J Med"},{"key":"R22-20261119","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1097\/TP.0000000000005296","article-title":"Tissue-based gene expression diagnosis of mild and moderate T-cell-mediated rejection to guide therapy in kidney transplants.","volume":"109","author":"Kumar","year":"2025","journal-title":"Transplantation"},{"key":"R23-20261119","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nbt1385","article-title":"Direct multiplexed measurement of gene expression with color-coded probe pairs.","volume":"26","author":"Geiss","year":"2008","journal-title":"Nat Biotechnol"},{"key":"R24-20261119","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1172\/JCI38248","article-title":"High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samples.","volume":"119","author":"Payton","year":"2009","journal-title":"J Clin Invest"},{"key":"R25-20261119","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1471-2407-14-177","article-title":"Analytical validation of the PAM50-based prosigna breast cancer prognostic gene signature assay and nCounter analysis system using formalin-fixed paraffin-embedded breast tumor specimens.","volume":"14","author":"Nielsen","year":"2014","journal-title":"BMC Cancer"},{"key":"R26-20261119","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-1-4939-9904-0_10","article-title":"NanoString nCounter technology: high-throughput RNA validation.","volume":"2079","author":"Goytain","year":"2020","journal-title":"Methods Mol Biol"},{"key":"R27-20261119","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1681\/ASN.2022040444","article-title":"Banff human organ transplant transcripts correlate with renal allograft pathology and outcome: importance of capillaritis and subpathologic rejection.","volume":"33","author":"Rosales","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"R28-20261119","doi-asserted-by":"crossref","first-page":"841519","DOI":"10.3389\/fimmu.2022.841519","article-title":"A decentralized kidney transplant biopsy classifier for transplant rejection developed using genes of the Banff-human organ transplant panel.","volume":"13","author":"van Baardwijk","year":"2022","journal-title":"Front Immunol"},{"key":"R29-20261119","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1097\/TP.0000000000004389","article-title":"Utility of Banff human organ transplant gene panel in human kidney transplant biopsies.","volume":"107","author":"Smith","year":"2023","journal-title":"Transplantation"},{"key":"R30-20261119","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/TP.0000000000004372","article-title":"Feasibility and potential of transcriptomic analysis using the NanoString nCounter technology to aid the classification of rejection in kidney transplant biopsies.","volume":"107","author":"Varol","year":"2023","journal-title":"Transplantation"},{"key":"R31-20261119","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.kint.2023.04.015","article-title":"Application of the Banff human organ transplant panel to kidney transplant biopsies with features suspicious for antibody-mediated rejection.","volume":"104","author":"Beadle","year":"2023","journal-title":"Kidney Int"},{"key":"R32-20261119","doi-asserted-by":"crossref","first-page":"11710","DOI":"10.3389\/ti.2023.11710","article-title":"Banff human organ transplant consensus gene panel for the detection of antibody mediated rejection in heart allograft biopsies.","volume":"36","author":"Giarraputo","year":"2023","journal-title":"Transpl Int"},{"key":"R33-20261119","doi-asserted-by":"crossref","first-page":"100304","DOI":"10.1016\/j.labinv.2023.100304","article-title":"Development and validation of a multiclass model defining molecular archetypes of kidney transplant rejection: a large cohort study of the Banff human organ transplant gene expression panel.","volume":"104","author":"Zhang","year":"2024","journal-title":"Lab Invest"},{"key":"R34-20261119","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.ekir.2024.04.054","article-title":"Relevance of the Banff human organ transplant consensus gene panel for detecting antibody and T-cell-mediated rejection of kidney allografts.","volume":"9","author":"Giarraputo","year":"2024","journal-title":"Kidney Int Rep"},{"key":"R35-20261119","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.ajt.2025.04.025","article-title":"Molecular diagnosis of kidney allograft rejection based on the Banff human organ transplant gene panel: a multicenter international study.","volume":"25","author":"Zielinski","year":"2025","journal-title":"Am J Transplant"},{"key":"R36-20261119","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1681\/ASN.2020030306","article-title":"Transcriptional changes in kidney allografts with histology of antibody-mediated rejection without anti-HLA donor-specific antibodies.","volume":"31","author":"Callemeyn","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"R37-20261119","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1111\/ajt.17092","article-title":"Molecular diagnosis of ABMR with or without donor-specific antibody in kidney transplant biopsies: differences in timing and intensity but similar mechanisms and outcomes.","volume":"22","author":"Halloran","year":"2022","journal-title":"Am J Transplant"},{"key":"R38-20261119","doi-asserted-by":"crossref","first-page":"864730","DOI":"10.3389\/fimmu.2022.864730","article-title":"Microvascular inflammation of the renal allograft: a reappraisal of the underlying mechanisms.","volume":"13","author":"Lebraud","year":"2022","journal-title":"Front Immunol"},{"key":"R39-20261119","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ajt.2024.07.023","article-title":"The relationship of microvascular inflammation with antibody-mediated rejection in kidney transplantation.","volume":"25","author":"Nankivell","year":"2025","journal-title":"Am J Transplant"},{"key":"R40-20261119","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJMoa2408835","article-title":"Microvascular inflammation of kidney allografts and clinical outcomes.","volume":"392","author":"Sablik","year":"2025","journal-title":"N Engl J Med"},{"key":"R41-20261119","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/ajt.15074","article-title":"Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: clinical presentation and implications for outcome.","volume":"19","author":"Senev","year":"2019","journal-title":"Am J Transplant"},{"key":"R42-20261119","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1038\/s41467-019-13113-5","article-title":"Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants.","volume":"10","author":"Koenig","year":"2019","journal-title":"Nat Commun"},{"key":"R43-20261119","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1097\/TP.0000000000002487","article-title":"Clinical significance of microvascular inflammation in the absence of anti-HLA DSA in kidney transplantation.","volume":"103","author":"Parajuli","year":"2019","journal-title":"Transplantation"},{"key":"R44-20261119","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1681\/ASN.2020111558","article-title":"Missing self-induced microvascular rejection of kidney allografts: a population-based study.","volume":"32","author":"Callemeyn","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"R45-20261119","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1097\/TP.0000000000003797","article-title":"Histologic antibody-mediated kidney allograft rejection in the absence of donor-specific HLA antibodies.","volume":"105","author":"Filippone","year":"2021","journal-title":"Transplantation"},{"key":"R46-20261119","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.kint.2021.11.029","article-title":"Allorecognition and the spectrum of kidney transplant rejection.","volume":"101","author":"Callemeyn","year":"2022","journal-title":"Kidney Int"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005822","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T11:00:25Z","timestamp":1795086025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/TP.0000000000005822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005822","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"2025-12-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}